|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| New contraceptive method, female-worn condom, approved by FDA panel. |
| WASHINGTON MEMO. 1992 FEb 19;(4):3-4. |
| An expedited review of the Reality intravaginal pouch--the so-called "female condom"--led the Food and Drug |
| Administration (FDA) to recommend conditional approval for the new contraceptive device on January 31. Developed |
| by the Wisconsin Pharmacal Company, Reality consists of a lubricated polyurethane sheath that is the same length |
| but wider than a male condom, and contains flexible rings at both ends. The closed end is inserted similarly to the |
| diaphragm, covering the cervix. The open end remains outside the vagina in order to prevent skin contact, thereby |
| preventing pregnancy and protecting against STD. Nonetheless, questions linger as to the efficacy of the device. In |
| 1988, an FDA expert panel determined that female condoms were not "substantially equivalent" to male condoms. |
| Soon after, however, the FDA issued new guidelines which streamlined the approach for bringing to market female |
| barrier contraceptives which offer protection against STDs. The FDA's January meeting was marked by a debate |
| between those supporting the expedited process, who viewed approval of the product as a moral imperative for |
| protecting women, and those questioning the efficacy of the product, who said that not enough information is |
| available. The latter group noted that one study found a 15.1% pregnancy rate among a group of women using the |
| device. The FDA decided to grant conditional approval; pending further company data on the use-effectiveness of |
| the device. Noting that expedited decision reflects the relatively slow pace and lack of federal support for |
| contraceptive research, the article goes on to discuss a legislative attempt to give permanent authorization for five |
| contraceptive and infertility research centers, a move that is not supported by the Bush administration. |
| (PubHealth.info Document ID: CONT3T 1576-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "New contraceptive method, female-worn condom, approved |
| by FDA panel.", is(are) . The source of this article is "WASHINGTON MEMO. 1992 FEb 19;(4):3-4.". This article was |
| published in 1992 in English language(s). (PubHealth.info® Document ID: CONT3T 1576-06. All rights reserved with |
| PubHealth.info) PIN: 11576 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
